None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A patient or legal representative voluntarily decides to participate in this clinical study and signs and seals the subject's written consent to participate in the study
Exclusion criteria
Exclusion criteria: 1. Patient scheduled for emergency surgery 2. Patient who cannot communicate 3. Patient who is pregnant or nursing 4. Patient who is unable to insert a sensor into the rear of the upper arm 5. Patients taking drugs (Hydroxyurea, acetaminophen, paracetamol) that can affect the sensor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Agreement rate 20/20 | — |
Secondary
| Measure | Time frame |
|---|---|
| Agreement rate 15/15;Agreement rate 30/30;Agreement rate 40/40;Mean absolute relative difference;FDA continuous glucose monitoirng system validation criteria;Sensor failture rate;Adverse event rate;Patient satisfaction;Error grid analysis | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Seoul St. Mary's Hospital